Distinguishing Isomeric Caffeine Metabolites through Protomers and Tautomers using Cryogenic Gas-Phase Infrared Spectroscopy
Caffeine is metabolised through various pathways in the human body, with the primary steps yielding isomeric products. Distinguishing these metabolites is crucial for mass spectrometry-based metabolomics, for example to assess specific drug interactions. Here, we investigate the gas-phase structures of caffeine and its metabolites theophylline, theobromine, paraxanthine, 1-methylxanthine, 3-methylxanthine and 7-methylxanthine in their respective protonated ions using cryogenic gas-phase infrared spectroscopy and supported by density functional theory. The analytes exhibited varying preferences for protonation and tautomerism, particularly N9 protonation and, where applicable, a tendency for N3O2 and N1O2 amide – imidic acid and N7N9 imine – imine tautomerism. We further demonstrate that the two isomeric sets of caffeine metabolites can easily be distinguished with gas-phase IR spectroscopy, paving the route for robust identification of such molecules in metabolomics using hyphenated gas-phase techniques.
Authors
- Kevin Pagel (ORCID: https://orcid.org/0000-0001-8054-4718)
- Gerard Meijer (ORCID: https://orcid.org/0000-0001-9669-8340)
- Gurpur Rakesh D. Prabhu (ORCID: https://orcid.org/0000-0002-3237-212X)
- Caitlin Walton‐Doyle (ORCID: https://orcid.org/0000-0001-7123-3336)
- Niklas Geue (ORCID: https://orcid.org/0000-0002-5216-8353)
- Gert von Helden (ORCID: https://orcid.org/0000-0001-7611-8740)
- Eleonora Renzi (ORCID: https://orcid.org/0009-0008-2869-5963)
Institutions
- Fritz Haber Institute of the Max Planck Society (DE)
- Freie Universität Berlin (DE)
Publication Details
- Journal
- ChemRxiv
- Published
- 2025-08-30
- DOI
- https://doi.org/10.26434/chemrxiv-2025-7xjpx
- Primary Topic
- Analytical Chemistry and Chromatography
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alexander von Humboldt-Stiftung
- Deutsche Forschungsgemeinschaft
- European Research Council
- H2020 Marie Skłodowska-Curie Actions